danyanghongxia

McKesson Specialty Care Solutions is a partner to pharmaceutical manufacturers in the development and execution of complex REMS programs, many of which require intense monitoring and controlled distribution to Chopard Mille Miglia CH-13 pharmacies. This requirement makes it more difficult for patients to obtain prescriptions than from their neighborhood retail pharmacy. By leveraging RelayHealth's pharmacy network, ProStrakan is able to make Abstral available for dispensing through retail pharmacy locations.

U.S. retail pharmacy prescription claims - including Medicare Part D claims - are processed over the RelayHealth Pharmacy Solutions network. The Abstral REMS program uses real-time, electronic dispensing "triggers" via Chopard Mille Miglia CH-78 network to verify enrollment of the prescriber and pharmacy, and support patient enrollment and verification. RelayHealth connectivity also helps prompt the pharmacist to provide a Chopard Mille Miglia Chronograph CH-10 Guide and counseling to enable safer use during the prescription's drug life cycle. Because prescription claims are auto-adjudicated in real time before being dispensed to patients, RelayHealth can embed business rules to identify whether all safe-use conditions and requirements of the program have been met without disrupting the pharmacist's workflow.

"ProStrakan's desire to expand Abstral's availability to patients within their communities is laudable," said Jeff Felton, president, RelayHealth Pharmacy Solutions. "The Abstral REMS program will make it possible for a patient prescribed the drug as an important part of Chopard Mille Miglia GMT CH-73 pain therapy to have their prescription filled at a local retail pharmacy that is enrolled in the Abstral REMS program. We are pleased to collaborate with ProStrakan in helping identify and monitor medication compliance and assisting individuals manage their pain and treatment progress more safely and effectively."